| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.37 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.36 | 0.06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | 0.27 | 0.06 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |